Exenatide0 vendors competing
No vendor pricing available for this peptide yet.
Research details
Exenatide — research data
Regulatory statusFDA-approved (Byetta/Bydureon)
NCAA D1Not listed
Overview
About Exenatide
Mechanism of action
GLP-1 receptor agonist; slows gastric emptying and stimulates insulin secretion
Safety profile
Nausea, vomiting, pancreatitis risk · Long clinical track record; GI side effects; rare pancreatitis reports
Related pages